ClinicalTrials HQ

RTX001 Autologous Engineered Macrophages for Liver Cirrhosis

RTX001 Autologous Engineered Macrophages for Liver Cirrhosis

Active, not recruiting · NCT06823713 · Registry updated 2026-10-05
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
RTX001 Autologous Engineered Macrophages for Liver CirrhosisBrain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Jaundice, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, brain disorder, central nervous system disorder, chronic liver failure, cirrhosis of liver, hepatic encephalopathy, hyperbilirubinemia, liver disorder, liver failure, metabolic disease, nervous system disorderActive, not recruitingPhase 1 / Phase 22026-10-05NCT06823713

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Resolution Therapeutics Limited2

15 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Bristol Royal InfirmaryBristolUnited Kingdom8
Glasgow Royal InfirmaryGlasgowUnited Kingdom8
Hospital General Universitario Gregorio MarañonMadridSpain72
Hospital Le FeValenciaSpain1
Hospital Universitari Vall d'HebronBarcelonaSpain200
Hospital Universitario La PazMadridSpain217
Hospital Universitario Ramón y CajalMadridSpain87
Hospital Universitario Reina SofíaCórdobaSpain29
Hospital Universitario Virgen del RocíoSevilleSpain68
King's College HospitalLondonUnited Kingdom57
Nottingham University HospitalNottinghamUnited Kingdom6
Royal Infirmary of EdinburghEdinburghUnited Kingdom17
Royal Liverpool University HospitalLiverpoolUnited Kingdom2
St George's HospitalLondonUnited Kingdom15
St Mary's HospitalLondonUnited Kingdom3